Development of an in vitro system and model-based translational framework to assess haemolysis risk following intravenous abuse of medications containing polyethylene oxide
Autor: | Eric Galia, Gerwin E. Engels, Peter Persich, Susanne Thun, Stéphan Benay, Willem van Oeveren |
---|---|
Rok vydání: | 2020 |
Předmět: |
Risk
0301 basic medicine Erythrocytes Thrombotic microangiopathy Guinea Pigs Excipient Pharmacology Toxicology Hemolysis Models Biological Polyethylene Glycols Excipients Hemoglobins 03 medical and health sciences 0302 clinical medicine In vivo medicine Animals Humans Substance Abuse Intravenous Cells Cultured business.industry General Medicine Polyethylene oxide medicine.disease Haemolysis 030104 developmental biology 030220 oncology & carcinogenesis In vitro system Time course Oxymorphone Hydrochloride business medicine.drug |
Zdroj: | Toxicology in Vitro. 65:104776 |
ISSN: | 0887-2333 |
DOI: | 10.1016/j.tiv.2020.104776 |
Popis: | Multiple cases of potentially life-threatening thrombotic microangiopathy (TMA) have resulted from intravenous abuse of medications containing polyethylene oxide (PEO), most often Opana ER (oxymorphone hydrochloride extended release). No validated models are available to assess the risk of TMA with different formulations and extraction methods following intravenous abuse. We have developed an in vitro system that involves passing pooled blood containing the excipient of interest through a syringe needle and assessing haemolysis via haemoglobin release. Haemolysis is induced by high shear stress caused by the flow of blood containing PEO through a narrow-bore syringe needle, recapitulating the mechanism in small blood vessels. Using the in vitro system, we demonstrate that high-molecular-weight PEO (>1 MDa) induces haemolysis in a concentration-dependent manner under flowing but not static conditions. We use data from the in vitro system and published in vivo data to predict the time course of the haemolytic response in vivo via a pharmacometric model. The in vitro system is a novel method for investigating factors influencing PEO-induced haemolysis. In combination with our model-based translational framework, the in vitro system allows straightforward assessment of the haemolytic potential of PEO-containing medications, and may find application in gauging TMA risk following intravenous abuse. |
Databáze: | OpenAIRE |
Externí odkaz: |